Telmisartan
Generic Name: Telmisartan
Uses & Medical Indications
Treatment of hypertension, cardiovascular risk reduction
Hypertension, Cardiovascular risk
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Telmisartan relaxes tight blood vessels and supports regular cardiac pumping, keeping blood pressure within a healthy range and protecting heart health.
Clinical Mechanism of Action (MoA)
Telmisartan lowers elevated blood pressure and relieves myocardial workload by inducing systemic vasodilation, antagonizing adrenergic sympathetic tone, or inhibiting the renin-angiotensin-aldosterone axis.
Dosage & Administration Guidelines
40 mg once daily
Not recommended
No initial dosage adjustment necessary
80 mg once daily
No initial dosage adjustment needed
Not recommended in severe hepatic impairment
Side Effects & Safety Warnings
Sinus pain, congestion, back pain, diarrhea
Hypotension, hyperkalemia, renal function deterioration
Hypersensitivity, coadministration with aliskiren in diabetic patients
Fetal toxicity, dual blockade of the renin-angiotensin system
Interactions (Drugs, Food & Alcohol)
NSAIDs, lithium, potassium-sparing diuretics
N/A
May increase hypotensive effect
Pregnancy & Breastfeeding Safety
Discontinue as soon as pregnancy is detected
Avoid breastfeeding
Patient Counseling & Practical Advice
May cause dizziness; avoid potassium supplements unless directed
Take as soon as remembered. Do not double dose.
Blood pressure, serum potassium, renal function
Related Medicines in Angiotensin II Receptor Blockers (ARBs)
When to Seek Urgent Medical Attention
Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.
Content for Telmisartan was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.